CI
Who in Congress traded CI, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Party Breakdown
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthMODERATEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
💼 Lobbying Filings
all →- 2026-04-21$50KCIGNAPharmacy issues related to TRICARE. Issues surrounding pharmacy benefit managers, and coverage of biosimilars.
- 2026-04-20$3.5MTHE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)Issues related to prior authorization; ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model Issues relating to implementation of the No Surprises Act H.R. 3838/S2296 Pharmacy issues related to the National Defense Authorization Act, FY2026 HR. 6400 / S. 4106 - Rx Access, Choice, Cost Equity, and Supply Stability (Rx ACCESS) Act S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; P.L. 119-75 Consolidated Appropriations Act, 2026 (H.R.7148) Issues related to the specialty drug market. H.R. 5582/S. 2355, Patients Deserve Price Tags Act Issues related to competition in the health care marketplace.
- 2026-04-20$1.7MTHE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)Issues related to prior authorization. S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues relating to implementation of the No Surprises Act. H.R. 3838/S. 2296 Pharmacy issues related to the National Defense Authorization Act, FY2026. "S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act." Issues related to the specialty drug market. Issues related to transparency. Issues related to competition in the health care marketplace.
- 2026-04-20$90KCIGNA CORPORATION AND SUBSIDIARIESIssues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260). Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60). Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
- 2026-04-20$60KTHE CIGNA GROUP AND SUBSIDIARIESIssues related to commercial insurance and pharmacy benefits. H.R.4710: No Surprises Act. H.R.7895: PBM Kickback Prohibition Act.
- 2026-04-19$20KTHE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)Pharmacy issues related to TRICARE; FY2027 Department of Defense Appropriations, FY2027 National Defense Authorization Act Issues related to P.L. 116-260, the No Surprises Act
- 2026-04-17$90KCIGNA CORPORATIONEducate lawmakers on issues related to pharmacy benefit managers and drug pricing; proposals impacting employer-sponsored insurance; and proposals related to telehealth. Monitor pharmacy issues related to TRICARE.
- 2026-04-17$90KCIGNA CORPORATIONProvide advice and counsel on healthcare coverage, surprise billing, drug pricing and Affordable Care Act issues Drug pricing and issues facing the pharmacy benefit manager industry generally
- 2026-04-17$50KCIGNA CORPORATE SERVICES LLC AND ITS AFFILIATESIssues related to health care policy including coverage and cost of care.
- 2026-04-16$0THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
Congressional Momentum
buy vs. sell pressureDISTRIBUTINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Best Timers
avg excess return vs SPY · CI trades only8 members w/ alpha dataExcess return = stock price change minus SPY change over the same holding window.Congress avg: -23.8%· 0% of traders beat SPY on this name
Timing Fingerprint
filing delay vs. excess return over SPY · 46 tradesCongress avg -21.4% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
Congress Swarm Events
synchronized trading — 3+ members within 21 daysHIGH ALERTA swarm event occurs when 3 or more members disclose trades in CI within a rolling 21-day window. Tight windows with high directional consensus score highest on the suspicion meter.
Trade Activity Timeline
Congressional buys & sells by month · last 24 months w/ activity
Who Moved First
each row = one member · sorted by earliest disclosed tradeSeasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Congressional Conviction Timeline
net positioning · alpha track recordBEARISHAll Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-05-15 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2026-04-24 | DRo Khanna | SELL | $1K – $15K | 17d | receipt → |
| 2026-04-13 | DRo Khanna | SELL | $15K – $50K | 28d | receipt → |
| 2026-03-23 | DJared Moskowitz | SELL | $1K – $15K | 39d | receipt → |
| 2026-03-23 | DJared Moskowitz | SELL | $1K – $15K | 38d | receipt → |
| 2026-03-13 | DGilbert Cisneros | SELL | $1K – $15K | 26d | receipt → |
| 2026-03-13 | DGilbert Cisneros | SELL | $1K – $15K | 25d | receipt → |
| 2026-02-24 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2026-02-17 | DRo Khanna | BUY | $1K – $15K | 20d | receipt → |
| 2026-01-13 | DRo Khanna | BUY | $1K – $15K | 24d | receipt → |
| 2025-12-18 | DJulie Johnson | SELL | $1K – $15K | 29d | receipt → |
| 2025-12-18 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-04-22 | RJulia Letlow | SELL | $1K – $15K | 267d | receipt → |
| 2025-12-19 | DGilbert Cisneros | BUY | $1K – $15K | 25d | receipt → |
| 2025-04-22 | RJulia Letlow | SELL | $1K – $15K | 266d | receipt → |
| 2024-10-23 | RJulia Letlow | BUY | $1K – $15K | 447d | receipt → |
| 2025-12-19 | DGilbert Cisneros | BUY | $1K – $15K | 24d | receipt → |
| 2025-11-12 | DGilbert Cisneros | SELL | $1K – $15K | 34d | receipt → |
| 2025-11-12 | DGilbert Cisneros | SELL | $1K – $15K | 33d | receipt → |
| 2025-11-13 | DJulie Johnson | SELL | $1K – $15K | 29d | receipt → |
| 2025-11-13 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-11-10 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2025-10-07 | DRo Khanna | BUY | $1K – $15K | 30d | receipt → |
| 2025-09-23 | DValerie Hoyle | SELL | $1K – $15K | 17d | receipt → |
| 2025-09-23 | DValerie Hoyle | SELL | $1K – $15K | 17d | receipt → |
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 13d | receipt → |
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 12d | receipt → |
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 12d | receipt → |
| 2025-09-29 | DRo Khanna | SELL | $1K – $15K | 4d | receipt → |
| 2025-09-05 | DRo Khanna | BUY | $1K – $15K | 28d | receipt → |
| 2025-08-05 | DGilbert Cisneros | SELL | $1K – $15K | 41d | receipt → |
| 2025-08-14 | DJulie Johnson | SELL | $1K – $15K | 29d | receipt → |
| 2025-08-05 | DGilbert Cisneros | SELL | $1K – $15K | 38d | receipt → |
| 2024-10-29 | DValerie Hoyle | BUY | $1K – $15K | 318d | receipt → |
| 2025-08-14 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-08-04 | DRo Khanna | SELL | $1K – $15K | 36d | receipt → |
| 2025-07-25 | DRo Khanna | SELL | $1K – $15K | 13d | receipt → |
| 2025-05-15 | DJared Moskowitz | BUY | $1K – $15K | 46d | receipt → |
| 2025-05-15 | DJared Moskowitz | BUY | $1K – $15K | 43d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 42d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-15 | DJared Moskowitz | BUY | $1K – $15K | 16d | receipt → |
| 2025-05-15 | DJared Moskowitz | BUY | $1K – $15K | 16d | receipt → |
| 2025-03-19 | DJulie Johnson | BUY | $1K – $15K | 26d | receipt → |
| 2025-03-03 | DJulie Johnson | SELL | $1K – $15K | 42d | receipt → |
| 2025-03-12 | DRo Khanna | BUY | $1K – $15K | 29d | receipt → |
| 2025-03-03 | DJulie Johnson | SELL | $1K – $15K | 36d | receipt → |
| 2025-03-19 | DJulie Johnson | BUY | $1K – $15K | 15d | receipt → |
| 2025-02-25 | RRobert Bresnahan | SELL | $1K – $15K | 30d | receipt → |
| 2025-02-24 | RJefferson Shreve | BUY | $15K – $50K | 13d | receipt → |
| 2025-02-25 | DRo Khanna | BUY | $1K – $15K | 9d | receipt → |
| 2025-01-13 | RRobert Bresnahan | SELL | $1K – $15K | 31d | receipt → |
| 2025-01-15 | DJulie Johnson | BUY | $1K – $15K | 28d | receipt → |
| 2025-01-24 | DGilbert Cisneros | SELL | $1K – $15K | 18d | receipt → |
| 2025-01-22 | DRo Khanna | BUY | $1K – $15K | 15d | receipt → |
| 2025-01-17 | DRo Khanna | BUY | $1K – $15K | 20d | receipt → |
| 2024-10-14 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2024-08-02 | DRo Khanna | SELL | $15K – $50K | 35d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-07-01 | DRo Khanna | BUY | $1K – $15K | 37d | receipt → |
| 2024-05-29 | DRo Khanna | SELL | $1K – $15K | 7d | receipt → |
| 2024-05-28 | DRo Khanna | SELL | $15K – $50K | 8d | receipt → |
| 2023-12-14 | RJerry Moran | SELL | $1K – $15K | 34d | receipt → |
| 2021-12-21 | RJerry Moran | BUY | $1K – $15K | 615d | receipt → |
| 2023-05-31 | DLois Frankel | BUY | $1K – $15K | 22d | receipt → |
| 2023-04-05 | DLois Frankel | BUY | $1K – $15K | 23d | receipt → |